MICHELLE DELA PENA: Open Payments
NPI 1811518178 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 116 payments from 16 companies in 2025. Trend: 2023 $1,699 · 2024 $2,077 · 2025 $2,607
Food & beverage: $2,590Education: $17
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $439 |
| Vanda Pharmaceuticals Inc. | 17 | $431 |
| E.R. Squibb & Sons, L.L.C. | 11 | $239 |
| Lundbeck LLC | 10 | $231 |
| Otsuka America Pharmaceutical, Inc. | 8 | $197 |
| Axsome Therapeutics, Inc. | 8 | $193 |
| Janssen Pharmaceuticals, Inc | 8 | $148 |
| Neurocrine BioSciences, Inc. | 5 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $141 |
| Teva Pharmaceuticals USA, Inc. | 6 | $109 |
Products named: VRAYLAR, FANAPT, REXULTI, COBENFY, SPRAVATO, INGREZZA, CAPLYTA, Auvelity.
Industry payments across IL — which companies pay providers there.
